KR840007409A - 복소환 또는 치환에 의해 6위치에 치환된 아미드화 피리다진 유도체의 제조방법 - Google Patents

복소환 또는 치환에 의해 6위치에 치환된 아미드화 피리다진 유도체의 제조방법 Download PDF

Info

Publication number
KR840007409A
KR840007409A KR1019840000274A KR840000274A KR840007409A KR 840007409 A KR840007409 A KR 840007409A KR 1019840000274 A KR1019840000274 A KR 1019840000274A KR 840000274 A KR840000274 A KR 840000274A KR 840007409 A KR840007409 A KR 840007409A
Authority
KR
South Korea
Prior art keywords
amine
pyridazine
chlorinated derivative
thienyl
methyl
Prior art date
Application number
KR1019840000274A
Other languages
English (en)
Other versions
KR910000641B1 (ko
Inventor
2) 쟝-뽈깡(외
Original Assignee
미쉘드 아스
소시에떼 아노님 사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미쉘드 아스, 소시에떼 아노님 사노피 filed Critical 미쉘드 아스
Publication of KR840007409A publication Critical patent/KR840007409A/ko
Application granted granted Critical
Publication of KR910000641B1 publication Critical patent/KR910000641B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음.

Description

복소환 또는 치환에 의해 6위치에 치환된 아미드화 피리다진 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 하기 일반식1의 염소화 유도체를 알콜과 같은 용매에서 수소산수용체 존재하고 온에서 하기 일반식2의 아민과 반응시키고, 필요하다면 수득된 유도체를 약학적으로 수용할 수 있는 염으로 전환시킴을 특징으로 하는 하기 일반식(I)의 아미드화 피리다진 유도체 및 그의 산부가염의 제조방법.
  2. (상기식중, R1은 2-티에닐, 3-티에닐 또는 시클로헥실기를 나타내고, R2는 저급 알킬기(1~4탄소원자) 또는 수소원자를 나타낸다.)
  3. 제1항에 있어서, 염소화 유도체가 케톤 R1-CO-CH3와 α-케토산 R2-CO-COOH를 축합하고, 수득된 α-히드록시 감마 케톤산을 히드라진 NH2-NH2와 반응시켜 상응하는 3-피리다존을 수득한 후, 이를 포스포리스 옥시클로라이드와 반응시킴으로써 수득됨을 특징으로 하는 방법.
  4. 제1항에 있어서, 염소화 유도체가 3클로로 4-메틸 6-(2-티에닐)피리다진이고 아민이 2-모르폴리노에틸아민인 방법.
  5. 제1항에 있어서, 염소화 유도체가 3-클로로 4-메틸 6-(3-티에닐) 피리다진이고 아민이 2-모르폴리노에틸 아민인 방법.
  6. 제1항에 있어서, 염소화 유도체가 3-클로로 4-메틸 6-시클로헥실 피리다진이고 아민이 2-모르폴리노에틸 아민인 방법.
  7. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000274A 1983-01-24 1984-01-23 복소환 또는 치환에 의해 6위치에 치환된 아미노화 피리다진 유도체의 제조방법 KR910000641B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301029 1983-01-24
FR8301029A FR2539742B1 (fr) 1983-01-24 1983-01-24 Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
KR840007409A true KR840007409A (ko) 1984-12-07
KR910000641B1 KR910000641B1 (ko) 1991-01-31

Family

ID=9285222

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000274A KR910000641B1 (ko) 1983-01-24 1984-01-23 복소환 또는 치환에 의해 6위치에 치환된 아미노화 피리다진 유도체의 제조방법

Country Status (24)

Country Link
US (1) US4524070A (ko)
EP (1) EP0117171B1 (ko)
JP (1) JPS59139367A (ko)
KR (1) KR910000641B1 (ko)
AT (1) ATE28077T1 (ko)
AU (1) AU560542B2 (ko)
CA (1) CA1218063A (ko)
CS (1) CS241539B2 (ko)
DD (1) DD238793A5 (ko)
DE (1) DE3464491D1 (ko)
DK (1) DK31584A (ko)
ES (1) ES529007A0 (ko)
FI (1) FI840268A (ko)
FR (1) FR2539742B1 (ko)
GR (1) GR81717B (ko)
HU (1) HU192390B (ko)
IE (1) IE840150L (ko)
IL (1) IL70757A (ko)
NO (1) NO840244L (ko)
NZ (1) NZ206907A (ko)
PT (1) PT77982B (ko)
SU (1) SU1189345A3 (ko)
YU (1) YU12384A (ko)
ZA (1) ZA84501B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2269788A (en) * 1987-08-19 1989-03-09 Erich-Klaus Martin Process for purifying and regenerating used oils
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
AU2005260102A1 (en) * 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292443A (en) * 1968-11-01 1972-10-11 Ct D Etudes Experimentales Et New pyridazine derivatives and process for their preparation
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives

Also Published As

Publication number Publication date
ES8407043A1 (es) 1984-09-01
PT77982A (fr) 1984-02-01
HU192390B (en) 1987-06-29
FR2539742A1 (fr) 1984-07-27
AU2372784A (en) 1984-07-26
US4524070A (en) 1985-06-18
GR81717B (ko) 1984-12-12
NZ206907A (en) 1987-03-31
KR910000641B1 (ko) 1991-01-31
DK31584A (da) 1984-07-25
DE3464491D1 (en) 1987-08-06
IL70757A0 (en) 1984-04-30
CS53084A2 (en) 1985-07-16
DK31584D0 (da) 1984-01-24
SU1189345A3 (ru) 1985-10-30
ZA84501B (en) 1984-09-26
IE840150L (en) 1984-07-24
ES529007A0 (es) 1984-09-01
PT77982B (fr) 1986-04-10
DD238793A5 (de) 1986-09-03
ATE28077T1 (de) 1987-07-15
FR2539742B1 (fr) 1986-09-05
YU12384A (en) 1986-10-31
EP0117171A1 (fr) 1984-08-29
CS241539B2 (en) 1986-03-13
FI840268A0 (fi) 1984-01-23
AU560542B2 (en) 1987-04-09
FI840268A (fi) 1984-07-25
JPS59139367A (ja) 1984-08-10
NO840244L (no) 1984-07-25
CA1218063A (en) 1987-02-17
EP0117171B1 (fr) 1987-07-01
IL70757A (en) 1986-12-31

Similar Documents

Publication Publication Date Title
KR870000312A (ko) 티아졸리딘-4(s)-카르복실산 유도체의 제조 방법
KR920008018A (ko) 피페라진 유도체의 제조방법
KR840007409A (ko) 복소환 또는 치환에 의해 6위치에 치환된 아미드화 피리다진 유도체의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR840000481A (ko) 페녹시벤조산으로 부터 유도된 제초성 화합물의 제조방법
KR830005191A (ko) 푸란유도체의 제조방법
KR910011839A (ko) 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제
KR890011830A (ko) 2-옥시이미노 -3- 옥소부티르산의 제조방법
KR870002110A (ko) 구아니디노티아졸 유도체의 제조방법
KR840003642A (ko) 에르고트 5's-(2r-부틸)펩티드 알카로이드의 제조방법
KR830009044A (ko) 3,5-디-3급부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR830003474A (ko) 2-r-6-py-3(2h)-피리다지논이나 약제학적으로 가능한 그의 산부가염류의 제조방법
KR830005203A (ko) 6-(피리디닐)-4-치환-3(2h)-피리다지논의 제조방법
KR840000516A (ko) 아미도벤즈아미드류의 제법
KR840006993A (ko) 피리딘 유도체
KR830003458A (ko) 2-티옥소-3-벤조치아졸린 아세토니트릴의 유도체
KR910011785A (ko) 피페리딘유도체 염산염의 제조방법
KR890014504A (ko) 4-(2'-시아노 에틸티오)메틸-2-구아니디노티아졸의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR900006295A (ko) 할로게노-4-메틸피라졸류 및 그의 제조방법
KR840002848A (ko) 유기인산염의 제조방법
KR840000564A (ko) 세팔로스포란산의 제조방법
KR910000733A (ko) 피롤리진 유도체 제조방법
KR830005153A (ko) 4-벤조일-5-히드록시피라졸계 화합물의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee